Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study

Oral direct-acting antiviral (DAA) treatment leads to >95% sustained virological response (SVR) and could be clinically useful in regression of liver fibrosis in chronic hepatitis C virus (HCV) infection. We evaluated if ledipasvir/sofosbuvir or sofosbuvir + ribavirin is associated with regressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozaki, Akito, Chuma, Makoto, Hara, Koji, Moriya, Satoshi, Fukuda, Hiroyuki, Numata, Kazushi, Tanaka, Katsuaki, Morimoto, Manabu, Sakamaki, Kentaro, Yamanaka, Takeharu, Kondo, Masaaki, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281984/
https://www.ncbi.nlm.nih.gov/pubmed/33761674
http://dx.doi.org/10.1097/MD.0000000000025110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281984/
https://www.ncbi.nlm.nih.gov/pubmed/33761674
http://dx.doi.org/10.1097/MD.0000000000025110

Ejemplares similares